Szerző: " Mahaffey Kenneth W."

Mahaffey Kenneth W.; Jardine Meg J.; Bompoint Severine; Cannon Christopher P.; Neal Bruce; Heerspink Hiddo J.L.; Charytan David M.; Edwards Robert; Agarwal Rajiv; Bakris George; Bull Scott; Kollaborációs szervezet: REDENCE Study Investigators; Keltai Katalin; Takács Róbert; et al.: Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups Results From the Randomized CREDENCE Trial.
CIRCULATION, 140 (9). pp. 739-750. ISSN 0009-7322 (2019)

Jardine Meg J.; Mahaffey Kenneth W.; Neal Bruce; Agarwal Rajiv; Bakris George L.; Brenner Barry M.; Kollaborációs szervezet: CREDENCE study investigators; Csecsei Gyöngyi; Csiky Botond; Danos Péter; Deák László; Dudás Mihály; Keltai Katalin; Takács Róbert; Rosivall László; et al.: The canagliflozin and renal endpoints in diabetes with established nephropathy clinical evaluation (CREDENCE) study rationale, design, and baseline characteristics.
AMERICAN JOURNAL OF NEPHROLOGY, 46 (6). pp. 462-472. ISSN 0250-8095 (2017)